Skip to main content
editorial
. 2024 Feb 20;76(1):1–5. doi: 10.1016/j.ihj.2024.02.001

Table 2.

Summarizing targeted therapies for HPV specifically aimed at reducing cardiac diseases.

Therapy Mechanism of Action Potential Impact on Cardiac Diseases
Antiviral Agents Inhibit HPV replication and spread60 Potential reduction in HPV-related inflammation, possibly reducing cardiac complications associated with HPV.
Immunotherapy Boost the immune response against HPV.61 Strengthened immune defense might limit HPV-related cardiac inflammation.
Vaccination Preventive measure against HPV infection.62 Reduction in HPV incidence could lower the risk of subsequent cardiac diseases related to persistent HPV.
Anti-inflammatory Agents Target inflammation caused by HPV infection63 Reduction in systemic inflammation, potentially benefiting cardiac health.
Antioxidants Combat oxidative stress linked to HPV64 Minimization of oxidative damage, potentially reducing cardiac complications associated with HPV-induced inflammation.
Regular Screening And Management Early detection of HPV and related complications. Prompt intervention and management could prevent or mitigate cardiac issues.
Lifestyle Modifications Healthy diet, exercise, and stress management. Strengthen overall immune response, potentially reducing HPV-related cardiac complications.